Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstract
Abstracts
Author Reply
Author's Reply
Book Review
Brief Communication
Case Report
Case Series
Commentary
Continuing Medical Education
Diagnosis
Down the Memory Lane
Editorial
EDITORIAL BOARD 2026-41-3
Erratum
Faculty
Free papers: Oral Session
Free papers: Poster Session
From Editor's desk
From The Chair, Scientific Committee
Guest Editorial
Image Challenge
In Memoriam
Interesting Image
Interesting Images
Invited Review
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Message
Message by President Elect, SNM, India
Message by President, SNM, India
Messages
Obituary
Oral
ORAL PRESENTATION
Original Article
Pictorial Essay
Pictorial Teaching Essay
POSTER PRESENTATION
President's Message
Presidents’ Wall of Fame
Review
Review Article
Schedule for Paper Presentations
Scientific Program
Secretary's Message
Short Communication
SNM India Guidelines 1.0
Technical Communication
Technical Note
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Abstract
Abstracts
Author Reply
Author's Reply
Book Review
Brief Communication
Case Report
Case Series
Commentary
Continuing Medical Education
Diagnosis
Down the Memory Lane
Editorial
EDITORIAL BOARD 2026-41-3
Erratum
Faculty
Free papers: Oral Session
Free papers: Poster Session
From Editor's desk
From The Chair, Scientific Committee
Guest Editorial
Image Challenge
In Memoriam
Interesting Image
Interesting Images
Invited Review
Letter to Editor
Letter to the Editor
Letters to Editor
Letters to the Editor
Message
Message by President Elect, SNM, India
Message by President, SNM, India
Messages
Obituary
Oral
ORAL PRESENTATION
Original Article
Pictorial Essay
Pictorial Teaching Essay
POSTER PRESENTATION
President's Message
Presidents’ Wall of Fame
Review
Review Article
Schedule for Paper Presentations
Scientific Program
Secretary's Message
Short Communication
SNM India Guidelines 1.0
Technical Communication
Technical Note
View/Download PDF

Translate this page into:

Case Report
39 (
3
); 210-212
doi:
10.4103/ijnm.ijnm_24_24

Delusory Radioiodine Uptake in Endometriotic Ovarian Cyst

Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Address for correspondence: Dr. Farinaz Farhoudi, Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail: farhoudif.ff@gmail.com

Licence
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

Abstract

A 25-year-old woman with a known case of papillary thyroid carcinoma conventional type referred to our center for treatment with radioactive iodine after total thyroidectomy. She received 200 mCi of radioiodine, and in the whole-body scan 1 week after the radioiodine therapy, an area of increased absorption was seen on the right side of the pelvis, which was diagnosed as an endometriotic ovarian cyst in the follow-up examinations.

Keywords

Endometriotic ovarian cyst
false-positive radioactive iodine uptake
I-131 whole-body scan
ovarian cyst

Introduction

The management of patients diagnosed with differentiated thyroid carcinoma typically involves the surgical removal of the entire thyroid gland, followed by the administration of radioactive iodine therapy. To evaluate the possible presence of metastasis to the neck and other parts of the body, a whole-body scan and measurement of blood serum thyroglobulin level are used.[1] Understanding the underlying factors contributing to the erroneous uptake of radioactive iodine is crucial for preventing unnecessary additional examinations. Here, we report a case of false-positive radioiodine uptake in an endometriotic cyst of the right ovary.

Case Report

A 25-year-old woman, known case of papillary thyroid carcinoma conventional type, has been referred to this center for treatment with radioactive iodine after total thyroidectomy. She received 200 mCi of radioiodine for the second time due to rising thyroglobulin levels (Tg>500ng/ml) and in the scan 1 week after the radioactive iodine therapy, an area of radioiodine accumulation was seen on the right side of the pelvis [Figure 1]. To rule out the possibility of metastasis in the pelvic cavity, single-photon emission computed tomography (CT)-CT was done in which radioiodine accumulation was localized in a cystic lesion in the right adnexa, in favor of an ovarian cyst [Figure 2]. Further evaluation with magnetic resonance (MR) images before and after intravenous gadolinium administration revealed a cystic lesion in the right adnexa measuring 19 mm, which shows hyperintensity on T1-weighted images and hypointensity (shading) on T2-weighted images. The shading sign is a characteristic pattern of endometriotic cysts at MR imaging [Figure 3].

Anterior (blue arrow) and posterior (red arrow) views of whole-body scan one week after radioiodine therapy showing radioiodine accumulation in the right side of the pelvic cavity
Figure 1 Anterior (blue arrow) and posterior (red arrow) views of whole-body scan one week after radioiodine therapy showing radioiodine accumulation in the right side of the pelvic cavity
Single-photon emission computed tomography (CT)-CT (blue arrow) images showing I-131 uptake localizing to a cystic lesion in the right adnexa
Figure 2 Single-photon emission computed tomography (CT)-CT (blue arrow) images showing I-131 uptake localizing to a cystic lesion in the right adnexa
A cystic lesion is noted in the right adnexa measuring 19 mm, which shows hyperintensity on coronal T1-weighted image (a) and hypointensity (shading) on coronal T2-weighted image (b). The shading sign is a characteristic pattern of endometriotic cysts at magnetic resonance imaging. Coronal T1-fatsat sequence after the administration of intravenous gadolinium (c)
Figure 3 A cystic lesion is noted in the right adnexa measuring 19 mm, which shows hyperintensity on coronal T1-weighted image (a) and hypointensity (shading) on coronal T2-weighted image (b). The shading sign is a characteristic pattern of endometriotic cysts at magnetic resonance imaging. Coronal T1-fatsat sequence after the administration of intravenous gadolinium (c)

Discussion

Following a complete removal of the thyroid, patients undergo an I-131 whole-body scan to detect any remaining thyroid tissue or signs of cancer spread. Posttreatment whole-body scans may reveal more areas of radioactive iodine uptake compared to the initial diagnostic scan in 6% to 13% of cases.[1] The sodium iodide symporter (NIS) is a strong transporter of iodine, responsible for concentrating radioiodine into the active thyroid tissue.[23] NIS is also found in salivary glands and gastric mucosa,[4] resulting in the uptake of radioactive iodine at these locations. Iodine is eliminated through the urinary system, resulting in physiological absorption in the kidneys and bladder. In addition to these physiological locations, some nonthreatening conditions may also exhibit higher RAI avidity, including blockage of the nasolacrimal duct, thymus, Meckel’s diverticulum, cysts in the liver and kidneys, adrenal adenoma, vascular aneurysms, and nabothian cysts.[256] While uncommon, the literature has documented instances of RAI uptake in different types of ovarian cysts, including endometrioid cysts, mucinous ovarian cystadenomas, dermoid cysts, and simple ovarian cysts.[7891011] Receiving the lowest dose rate is one of the most important concerns in iodine therapy[12] so it is crucial to distinguish between these noncancerous conditions and metastases to prevent unnecessary treatments and exposure to radioactive iodine.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , , , , , , . 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1-133.
    [Google Scholar]
  2. , , , , , . Causes of false-positive radioactive iodine uptake in patients with differentiated thyroid cancer. Curr Radiol Rep. 2021;9:1-11.
    [Google Scholar]
  3. , , , , , , . False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer. Intern Med. 2013;52:2321-3.
    [Google Scholar]
  4. , , . Hiatal hernia uptake of iodine-131 mimicking mediastinal metastasis of papillary thyroid carcinoma. Indian J Nucl Med. 2015;30:347-9.
    [Google Scholar]
  5. , , . Incidentally visualization of the thymus on whole-body iodine scintigraphy: Report of 2 cases and review of the latest insights. Medicine (Baltimore). 2015;94:e1015.
    [Google Scholar]
  6. , , . Adrenocortical adenoma manifesting as false-positive iodine accumulation in a patient with history of thyroid carcinoma. Radiol Case Rep. 2018;13:949-51.
    [Google Scholar]
  7. , , , . Unusual uptake of (131)iodine in bilateral ovarian endometriosis cysts in a patient with thyroid cancer. Endocrine. 2019;66:693-4.
    [Google Scholar]
  8. , , , , , , . I-131 uptake in bilateral ovarian endometrial cysts. Clin Nucl Med. 2009;34:537-8.
    [Google Scholar]
  9. , , , , , , . Abnormal iodine-131 uptake in a benign mucinous ovarian cystadenoma mimicking struma ovarii. Clin Nucl Med. 2007;32:64-6.
    [Google Scholar]
  10. , , , , , , . Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: Report of a case and review of the literature. Arch Endocrinol Metab. 2015;59:351-4.
    [Google Scholar]
  11. , , , , , , . Aberrant radioactive iodine uptake in simple ovarian cyst: A rare finding. Indian J Nucl Med. 2023;38:387-9.
    [Google Scholar]
  12. , , , , , . Impact of the amount of liquid intake on the dose rate of patients treated with radioiodine. Indian J Nucl Med. 2018;33:10-3.
    [Google Scholar]
Show Sections